Active ingredient description

Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BE Artemisinin and derivatives
Discover more medicines within P01BE02

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₆H₂₆O₅
Molecular mass: 298.375 g/mol

External identifiers

CAS Substance: 71963-77-4
DrugBank Drug: DB06697
KEGG Drug: D02483
PubChem Compound: 68911
RxNorm Ingredient: 18343
SNOMED-CT Concept: 420578008
Artemether (substance)
UNII Identifier: C7D6T3H22J


Artemether is an active ingredient of these brands:

United States (US)

Australia (AU)

Austria (AT)

France (FR)

Japan (JP)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

South Africa (ZA)

United Kingdom (UK)

While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.